Tickers — A

175 tickers
Ranks this page's recent reports by score.
AnaptysBio, Inc.
ANAB·Healthcare
C ★★Sell
Current$49.24
Oct 20, 2026

AnaptysBio offers exposure to growing Jemperli royalties and potentially valuable regulatory catalysts, but substantial contractual uncertainty, weak cash conversion and shareholder dilution undermine the near-term investment case.

Score
57
ASML Holding N.V.
ASML·Technology
A ★★★★Buy
Current$1,641.52
Target$1,802.00
Return+9.8%
Oct 19, 2026

ASML's unrivaled EUV lithography position and expanding service revenue support long-term earnings compounding, although export restrictions, production bottlenecks, and demanding growth expectations constrain valuation upside.

Score
78
Aehr Test Systems, Inc.
AEHR·Technology
F Avoid
Current$69.21
Oct 16, 2026

Aehr could benefit from rapid AI processor and silicon photonics burn-in adoption, but its high valuation, concentrated customer programs, and unproven earnings recovery create substantial downside risk.

Score
46
Applied Digital Corporation
APLD·Technology
D ★Strong Sell
Current$23.25
Oct 12, 2026

Applied Digital offers exceptional AI data center growth backed by long-term contracts, but heavy construction spending, leverage, and shareholder dilution threaten the conversion of that growth into sustainable per-share value.

Score
55
Accenture plc
ACN·Technology
A ★★★★Buy
Current$196.64
Target$218.99
Return+11.4%
Oct 8, 2026

Accenture offers durable enterprise relationships, exceptional cash flow and historically inexpensive valuation with upside from AI transformation, although automation could compress traditional consulting revenue and margins.

Score
89
Acuity Inc.
AYI·Industrials
S ★★★★★Strong Buy
Current$308.76
Target$388.25
Return+25.8%
Oct 3, 2026

Acuity pairs a cash-rich lighting franchise with fast-growing Intelligent Spaces at a discounted valuation, though the thesis depends on AIS sustaining organic growth as acquisition comparisons normalize.

Score
90
AAR Corp.
AIR·Industrials
B ★★★Hold
Current$99.90
Target$139.20
Return+39.3%
Oct 2, 2026

AAR combines above-market aviation aftermarket growth with improving margins and a discounted post-selloff valuation, but the MRO Holdings deal adds substantial leverage, dilution, and integration risk.

Score
74
AutoZone, Inc.
AZO·Consumer Discretionary
B ★★★Hold
Current$2,872.16
Target$3,056.88
Return+6.4%
Sep 27, 2026

AutoZone's dense distribution network, commercial share gains and relentless buybacks support durable per-share compounding, but weaker DIY demand, falling capital efficiency and elevated FCF multiples constrain near-term upside.

Score
73
ABIVAX Société Anonyme
ABVX·Healthcare
D ★Strong Sell
Current$91.06
Sep 27, 2026

Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue valuation, binary FDA risk, and heavy dilution leave little margin for execution error.

Score
57
AeroVironment, Inc.
AVAV·Industrials
C ★★Sell
Current$153.40
Sep 15, 2026

AeroVironment is an advantaged defense-drone and counter-UAS platform with record backlog and major laser wins, but acquisition dilution, weak free cash flow, recent control failures and a demanding valuation keep risk-reward unattractive.

Score
62
American Eagle Outfitters, Inc.
AEO·Consumer Discretionary
B ★★★Hold
Current$15.43
Target$17.60
Return+14.1%
Sep 15, 2026

American Eagle Outfitters is a low-multiple turnaround driven by Aerie growth, strong shareholder returns and a possible core-brand recovery, but markdown pressure and one-time tariff-refund earnings keep normalized profitability uncertain.

Score
73
Adobe Inc.
ADBE·Technology
A ★★★★Buy
Current$252.23
Target$333.60
Return+32.3%
Sep 15, 2026

Adobe is a highly profitable, deeply embedded software franchise trading near historically depressed earnings and cash-flow multiples, with substantial upside if AI becomes an incremental monetization layer rather than a substitute for Creative Cloud.

Score
89